Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status

Free Radical Biology and Medicine

Volumn 50, Issue 9, 2011, Pages 1065-1074

  Hogg, Melissa E ^a   Varu, Vinit N ^a,b   Vavra, Ashley K ^a   Popowich, Daniel A ^a   Banerjee, Monisha N ^a   Martinez, Janet ^a   Jiang, Qun ^a   Saavedra, Joseph E ^c   Keefer, Larry K ^d   Kibbe, Melina R ^a,e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Cell cycle; Free radicals; Hormones; Neointimal hyperplasia; Nitric oxide; Vascular smooth muscle proliferation

Indexed keywords

CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 20; CYCLIN A; CYCLIN B; CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; HORMONE; NITRIC OXIDE; PROTEIN P21; PROTEIN P27;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CAROTID ARTERY INJURY; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HYPERPLASIA; IN VITRO STUDY; IN VIVO STUDY; MALE; NEOINTIMA HYPERPLASIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE CELL;

ANIMALS; AORTA; AZO COMPOUNDS; CAROTID ARTERY INJURIES; CASTRATION; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL CYCLE PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HORMONES; HYPERPLASIA; MALE; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; NITRIC OXIDE; NITRIC OXIDE DONORS; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS;

ANIMALIA; RATTUS;

EID: 79953240395     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.01.016     Document Type: Article

References (37)

1. M. Kibbe, T. Billiar, and E. Tzeng Inducible nitric oxide synthase and vascular injury Cardiovasc. Res. 43 1999 650 657 (Pubitemid 29369263)
2. S.S. Ahanchi, N.D. Tsihlis, and M.R. Kibbe The role of nitric oxide in the pathophysiology of intimal hyperplasia J. Vasc. Surg. 45 Suppl. A 2007 A64 A73
3. M.R. Kibbe, J. Li, S. Nie, S.C. Watkins, A. Lizonova, and I. Kovesdi Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate J. Vasc. Surg. 31 2000 1214 1228 (Pubitemid 30418493)
4. D. Lloyd-Jones, R. Adams, M. Carnethon, S.G. De, T.B. Ferguson, and K. Flegal Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 2008 e21 e181
5. E. Barrett-Connor, and T.L. Bush Estrogen and coronary heart disease in women JAMA 265 1991 1861 1867
6. B. Sigvant, K. Wiberg-Hedman, D. Bergqvist, O. Rolandsson, B. Andersson, and E. Persson A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences J. Vasc. Surg. 45 2007 1185 1191 (Pubitemid 46817840)
7. M.M. McDermott, L. Fried, E. Simonsick, S. Ling, and J.M. Guralnik Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning-the Women's Health and Aging Study Circulation 101 2000 1007 1012 (Pubitemid 30131703)
8. M.A. Enzler, M. Ruoss, B. Seifert, and M. Berger The influence of gender on the outcome of arterial procedures in the lower extremity Eur. J. Vasc. Endovasc. 11 1996 446 452 (Pubitemid 26192853)
9. S.C. Smith Jr., J.T. Dove, A.K. Jacobs, J.W. Kennedy, D. Kereiakes, and M.J. Kern ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) J. Am. Coll. Cardiol. 37 2001 2215 2239
10. L.A. Fitzpatrick, M. Ruan, J. Anderson, T. Moraghan, and V. Miller Gender-related differences in vascular smooth muscle cell proliferation: implications for prevention of atherosclerosis Lupus 8 1999 397 401 (Pubitemid 29378022)
11. D. Dai-Do, E. Espinosa, G.Z. Liu, T.J. Rabelink, F. Julmy, and Z.H. Yang 17β-Estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males Cardiovasc. Res. 32 1996 980 985 (Pubitemid 26342664)
12. F.D. Kolodgie, A. Jacob, P.S. Wilson, G.C. Carlson, A. Farb, and A. Verma Estradiol attenuates directed migration of vascular smooth muscle cells in vitro Am. J. Pathol. 148 1996 969 976 (Pubitemid 126660688)
13. P. Geraldes, M.G. Sirois, P.N. Bernatchez, and J.F. Tanguay Estrogen regulation of endothelial and smooth muscle cell migration and proliferation-role of p38 and p42/44 mitogen-activated protein kinase Arterioscler. Thromb. Vasc. 22 2002 1585 1590
14. M. Akishita, Y. Ouchi, H. Miyoshi, K. Kozaki, S. Inoue, and M. Ishikawa Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells Atherosclerosis 130 1997 1 10 (Pubitemid 27158023)
15. S.J. Chen, H.B. Li, J. Durand, S. Oparil, and Y.F. Chen Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery Circulation 93 1996 577 584 (Pubitemid 26043619)
16. D. Kurumazuka, T. Mori, and Y. Matsumura Ovariectomized female rats show more favorable response to atorvastatin than male rats against balloon injury J. Pharmacol. Sci. 97 2005 189P
17. H. Kaneda, J. Ako, T. Kataoka, T. Takahashi, M. Terashima, and Y. Shimada Impact of gender on neointimal hyperplasia following coronary artery stenting Circulation 112 2005 U834
18. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women-principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333 (Pubitemid 34761611)
19. M.J. Stampfer, W.C. Willett, G.A. Colditz, B. Rosner, F.E. Speizer, and C.H. Hennekens A prospective study of postmenopausal estrogen therapy and coronary heart disease N. Engl. J. Med. 313 1985 1044 1049 (Pubitemid 16243331)
20. M.J. Stampfer, G.A. Colditz, W.C. Willett, J.E. Manson, B. Rosner, and F.E. Speizer Postmenopausal estrogen therapy and cardiovascular-disease-10-year follow-up from the Nurses Health Study N. Engl. J. Med. 325 1991 756 762
21. L.K. Keefer Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates Annu. Rev. Pharmacol. Toxicol. 43 2003 585 607 (Pubitemid 37372654)
22. J.A. Hrabie, and L.K. Keefer Chemistry of the nitric oxide-releasing diazeniumdiolate ("nitrosohydroxylamine") functional group and its oxygen-substituted derivatives Chem. Rev. 102 2002 1135 1154 (Pubitemid 35377605)
23. M.R. Kapadia, L.W. Chow, N.D. Tsihlis, S.S. Ahanchi, J.W. Eng, and J. Murar Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia J. Vasc. Surg. 47 2008 173 182
24. S.S. Ahanchi, V.N. Varu, N.D. Tsihlis, J. Martinez, C.G. Pearce, and M.R. Kapadia Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome Am. J. Physiol. Heart Circ. Physiol. 295 2008 H2388 H2398
25. C.G. Pearce, S.F. Najjar, M.R. Kapadia, J. Murar, J. Eng, and B. Lyle Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia Free Radic. Biol. Med. 44 2008 73 81 (Pubitemid 350138632)
26. V.N. Varu, S.S. Ahanchi, M.E. Hogg, H.A. Bhikhapurwala, A. Chen, and D.A. Popowich Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes Am. J. Physiol. Heart Circ. Physiol. 299 2010 H772 H779
27. D.J. Waterhouse, J.E. Saavedra, K.M. Davies, M.L. Citro, X. Xu, and D.A. Powell Injectable formulation of disodium 1-[2-(carboxylato)pyrrolidin-1-yl] diazen-1-ium-1, 2-diolate (PROLI/NO), an ultrafast nitric oxide donor prodrug J. Pharm. Sci. 95 2006 108 115
28. S.M. Yu, L.M. Hung, and C.C. Lin cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway Circulation 95 1997 1269 1277
29. S. Gunther, R.W. Alexander, W.J. Atkinson, and M.A. Gimbrone Functional angiotensin-II receptors in cultured vascular smooth-muscle cells J. Cell Biol. 92 1982 289 298 (Pubitemid 12157405)
30. Y. Berthois, J.A. Katzenellenbogen, and B.S. Katzenellenbogen Phenol red in tissue-culture media is a weak estrogen-implications concerning the study of estrogen-responsive cells in culture Proc. Natl Acad. Sci. USA 83 1986 2496 2500 (Pubitemid 16026909)
31. R. Sarkar, D. Gordon, J.C. Stanley, and R.C. Webb Cell cycle effects of nitric oxide on vascular smooth muscle cells Am. J. Physiol. 272 4 Pt 2 1997 H1810 H1818
32. R. Sarkar, E.G. Meinberg, J.C. Stanley, D. Gordon, and R.C. Webb Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells Circ. Res. 78 1996 225 230 (Pubitemid 26042839)
33. S.H. Ling, A.Z. Dai, R.J. Dilley, M. Jones, E. Simpson, and P.A. Komesaroff Endogenous estrogen deficiency reduces proliferation and enhances apoptosis-related death in vascular smooth muscle cells-insights from the aromatase-knockout mouse Circulation 109 2004 537 543 (Pubitemid 38168519)
34. Z.H. Mnjoyan, D. Doan, J.L. Brandon, K. Felix, C.L. Sitter, and A.A. Rege The critical role of the intrinsic VSMC proliferation and death programs in injury-induced neointimal hyperplasia Am. J. Physiol. Heart Circ. Physiol. 294 2008 H2276 H2284
35. M.E. Mendelsohn Nongenomic, estrogen receptor-mediated activation of endothelial nitric oxide synthase-how does it work? What does it mean? Circ. Res. 87 2000 956 960
36. M.E. Mendelsohn Genomic and nongenomic effects of estrogen in the vasculature Am. J. Cardiol. 90 1A 2002 3F 6F (Pubitemid 34775144)
37. M.E. Mendelsohn Protective effects of estrogen on the cardiovascular system Am. J. Cardiol. 89 12A 2002 12E 17E